Product name: Rosiridin
Synonym name:
Catalogue No.: BP1223
Cas No.: 100462-37-1
Formula: C₁₆H₂₈O₇
Mol Weight: 332.393
Botanical Source: Rhodiolae Crenulatae Radixet Rhizoma
Physical Description:
Type of Compound: Monoterpenoids

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle

Storage: Store in a well closed container, protected from air and light. Put into refrigerate or freeze for long term storage.
Whenever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20℃. Generally, these will be useable for up to two weeks.

The product could be supplied from milligrams to grams
Inquire for bulk scale.

Description:

Rosiridin has cardioprotective activity.

References:

Journal of Xinjiang Medical University,2007, 30(2):127-9.    

The determination of rosiridin in effect extracts of anti-coronary atherosclerotic heart disease of Rhodiola rosea by HPLC   

To develop an assay method for determining the concentrations of Rosiridin in effect extracts of anti-coronary atherosclerotic heart disease of Rhodiola rosea. 

METHODS AND RESULTS:

High performance liquid chromatography detection (HPLC) was used, using a ODS C18 column (250 mm×4.6 mm, 5 μm) set at 35℃, methanol-water (35∶65) as mobile phase with flowing rate 0.8 ml/min and detected at 210 nm. The linear range of Rosiridin was 5.5~550 μg/ml (r=0.999 6), and the average recovery (n=9) was 98.5%, RSD=1.3%. 

CONCLUSIONS:

This method is simple, accurate and reproducible. It provides a basis for the quality evaluation for effect extracts of anti-coronary atherosclerotic heart disease of Rhodiola rosea.